Imperva (IMPV) Tops Q2 EPS by 7c

Go back to Imperva (IMPV) Tops Q2 EPS by 7c

Imperva (IMPV) PT Lowered to $59 at Susquehanna

July 27, 2018 8:56 AM UTC

Susquehanna lowered its price target on Imperva (NASDAQ: IMPV) to $59.00 (from $60.00) while maintaining a Positive rating.

Analyst Anne Meisner commented, "Imperva's stronger-than-expected mix-shift to subscription revenue drives lower guidance near term but should result in accelerating recurring revenue."

... More

DA Davidson Downgrades Imperva (IMPV) to Neutral Citing 2019 Being a Transition Year

July 27, 2018 6:39 AM UTC

DA Davidson downgraded Imperva (NASDAQ: IMPV) from Buy to Neutral with a price target of $46.00 (from $56.00).

For an analyst ratings summary and ratings history on Imperva click here. For more ratings news on Imperva click here.

Shares of Imperva closed at $56.70 yesterday.

... More

Oppenheimer Downgrades Imperva (IMPV) to Perform

July 27, 2018 6:08 AM UTC

Oppenheimer downgraded Imperva (NASDAQ: IMPV) from Outperform to Perform.

Analyst Shaul Eyal offers three reasons for the downgrade:

We clearly understand IMPV's model transition towards a subscription-driven one and are encouraged by FlexProtect's (hybrid product) strong traction, but we are slightly... More

Imperva (IMPV) PT Lowered to $47 at Deutsche Bank

July 27, 2018 5:51 AM UTC

Deutsche Bank lowered its price target on Imperva (NASDAQ: IMPV) to $47.00 (from $50.00) while maintaining a Hold rating.

... More

Imperva (IMPV) Announces Acquisition of Prevoty for $140M

July 26, 2018 4:46 PM UTC

Imperva, Inc. (NASDAQ: IMPV) today announced it signed an agreement to acquire Prevoty. Together, Imperva and Prevoty will provide comprehensive security solutions to protect application services residing on-premises and in the cloud. This solution aligns with how organizations are developing and deploying... More